New President & COO brings senior and benefits industry expertise to NIH’s leadership team

January 27, 2026 – DES MOINES, IOWA. NIH is a fast‑growing consulting firm specializing in healthcare design, data, pharmacy, and analytics, helping employers better manage healthcare costs while improving care quality and access to personalized services for their employees.

NIH has named Robert S. Shestack as its President & Chief Operating Officer. Prior to joining NIH, Mr. Shestack was most recently the Chief Revenue Officer at Juice Financial. Mr. Shestack also serves as the Chairman and CEO of the Health & Voluntary Benefits Association, a non-profit 501(c)(3) focused on education and networking opportunities related to providers and purchasers of healthcare and supplemental insurance programs. He will be responsible for leading NIH’s corporate strategy and growth efforts in the healthcare market as NIH continues to scale its industry-leading solutions. In addition, he will continue to focus on the growth and strategy of the HVBA.

“We are pleased to have Rob join our executive team and leading the strategy and operations of NIH,” said Jake Velie, Chairman & CEO. “Rob’s credentials, reputation and knowledge speak for themself. His extensive experience, leadership and benefits industry relationships make him an important part of our future growth. His strategic insight and industry perspectives will be a key addition in support of our strategic and growth efforts.”

Mr. Shestack has over 35 years of experience in strategic leadership roles in the healthcare space, across organizations such as Willis Towers Watson, AmeriFlex, USI, Marsh / Mercer, AmWINS, and Juice Financial. He holds undergraduate degrees in Actuarial Science, Risk Management and Business Law from Temple University.

“I am excited to join the NIH team,” said Shestack. “The challenges employers face in their healthcare spends and quality of care for their employees are underserved and a problem among brokers and their clients alike. Bringing NIH’s innovative solutions to this market offers a unique opportunity for employer to significantly reduce their healthcare spend, delivering more affordable and quality care improving the lives and wellness of their employees.”

About National Integrative Health

National Integrative Health (NIH) is a fiduciary pharmacy procurement and clinical services organization delivering one of the most advanced cost-plus pharmacy sourcing programs in the United States. NIH dramatically reduces the cost of high-cost brand, specialty, infusion, and cold-chain medications by leveraging the lowest net acquisition cost available globally or domestically. The program offers three customizable formularies—Global, Domestic, and U.S.-Only—each covering more than 7,000 NDCs and allowing plan sponsors to tailor sourcing based on regulatory, geographic, or strategic preferences. NIH integrates seamlessly with existing PBMs and provides full claims adjudication, rebate aggregation, copay assistance, data processing, and transparent reporting to ensure the lowest net cost to the plan. The platform also includes comprehensive U.S. and clinical programs such as 340B access, 503B direct manufacturing, infusion and site-of-care management, pharmacogenomics, GLP-1 management, and cell and gene therapy integration, with savings certified by actuaries nationwide.

Contact Information:

National Integrative Health
Jake Velie, Chairman & CEO
jvelie@nationalintegrativehealth.com
www.nationalintegrativehealth.com